The Vector Research Center on July 24 obtained the Healthcare Ministry’s permit to conduct clinical trials of its vaccine on volunteers. The first volunteer was inoculated on July 27.

The preclinical data generated by agents produced by the GLP practice can be valuable in the later development of clinical trials in gene therapy. To help investigators choose the optimum vector ...

“We have seen remarkable results from clinical trials using AAV vectors for AADC gene transfer,” says Shin-ichi Muramatsu, a pioneer of AAV vector research, and a professor in Jichi Medical ...

Human Immunodeficiency VirusImage: NIAIDThe Merck-funded STEP study, which used an adenoviral vector to deliver an HIV vaccine candidate, was halted in 2007 after the data suggested the vaccine ...

Ocugen (OCGN) announced that dosing is complete, ahead of schedule in the Phase 2 portion of the Phase 1/2 ArMaDa clinical trial for OCU410-a ...

Earlier the sanitary watchdog who runs the Vector center reported that 86 volunteers would receive the vaccine during the second phase of clinical trials. Russia, like any other country ...

In 2021, Tianjin-based biopharmaceutical company, CanSino Biologics (CanSinoBIO) completed a Phase III clinical trial of their intramuscular ... is a recombinant viral vector vaccine, a class ...